Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index <50 kg/m2?

Biliopancreatic diversion: the effectiveness of duodenal switch and its limitations. Gastroenterol Res Pract (2013) 0.77

Gastrointestinal Complications After Bariatric Surgery. Gastroenterol Hepatol (N Y) (2015) 0.75

Comment on: Is biliopancreatic diversion with duodenal switch indicated for patients with body mass index <50 kg/m2? Surg Obes Relat Dis (2010) 0.75

A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res (2004) 2.33

Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics (2006) 2.00

Body weight is a strong predictor of postural stability. Gait Posture (2006) 1.76

Perioperative complications in a consecutive series of 1000 duodenal switches. Surg Obes Relat Dis (2011) 1.55

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery (2004) 1.51

Intra-abdominal pressure in the morbidly obese. Obes Surg (2005) 1.47

Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg (2004) 1.45

Long-term experience with duodenal switch in adolescents. Obes Surg (2010) 1.44

Impact of bariatric surgery--induced weight loss on heart rate variability. Metabolism (2007) 1.43

[Expected body mass index after bariatric surgery]. Cir Esp (2009) 1.39

Differential methylation in glucoregulatory genes of offspring born before vs. after maternal gastrointestinal bypass surgery. Proc Natl Acad Sci U S A (2013) 1.28

Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation (2009) 1.12

Duodenal switch: long-term results. Obes Surg (2007) 1.07

ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics. Obes Surg (2007) 1.05

Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) (2009) 1.04

Health-related quality of life in morbid obesity. Obes Surg (2006) 1.04

Regional differences in adipose tissue metabolism in obese men. Metabolism (2007) 1.03

Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg (2006) 1.01

Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg (2004) 1.00

Outcome of pregnancies after biliopancreatic diversion. Obes Surg (2004) 0.98

Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects. Arterioscler Thromb Vasc Biol (2014) 0.96

Comprehensive genetic analysis of the dipeptidyl peptidase-4 gene and cardiovascular disease risk factors in obese individuals. Acta Diabetol (2008) 0.96

DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity (Silver Spring) (2010) 0.95

Long-Term Metabolic Outcomes 5 to 20 Years After Biliopancreatic Diversion. Obes Surg (2015) 0.92

Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids (2006) 0.92

Waist girth does not predict metabolic complications in severely obese men. Diabetes Care (2006) 0.92

Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients. J Obes (2013) 0.91

Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg Obes Relat Dis (2008) 0.91

Does bone change after biliopancreatic diversion? J Gastrointest Surg (2002) 0.90

Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome. Mol Genet Metab (2005) 0.88

Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity. Surg Obes Relat Dis (2009) 0.87

Plasma concentration of organochlorine compounds is associated with age and not obesity. Chemosphere (2006) 0.86

Blood pressure assessment in severe obesity: validation of a forearm approach. Obesity (Silver Spring) (2013) 0.86

Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg (2007) 0.85

Association of OSBPL11 gene polymorphisms with cardiovascular disease risk factors in obesity. Obesity (Silver Spring) (2009) 0.85

Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity. Obes Surg (2010) 0.84

Biliopancreatic diversion with duodenal switch improves insulin sensitivity and secretion through caloric restriction. Obesity (Silver Spring) (2014) 0.84

LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin Epigenetics (2012) 0.83

Gene expression variability in subcutaneous and omental adipose tissue of obese men. Gene Expr (2007) 0.82

Differential methylation in visceral adipose tissue of obese men discordant for metabolic disturbances. Physiol Genomics (2014) 0.82

Progesterone metabolism in adipose cells. Mol Cell Endocrinol (2008) 0.82

Thymic stromal lymphopoietin: an immune cytokine gene associated with the metabolic syndrome and blood pressure in severe obesity. Clin Sci (Lond) (2012) 0.81

Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes. Am J Physiol Endocrinol Metab (2012) 0.81

Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J Endocrinol (2006) 0.81

Predictors of weight loss in Parkinson's disease: is weight loss the chicken or the egg? Mov Disord (2007) 0.81

Impact of bariatric surgery on cardiac structure, function and clinical manifestations in morbid obesity. Expert Rev Cardiovasc Ther (2004) 0.80

Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients. Metabolism (2013) 0.78

Impact of orlistat-induced weight loss on diastolic function and heart rate variability in severely obese subjects with diabetes. J Obes (2010) 0.78

Accelerated satiation after duodenal switch. Surg Obes Relat Dis (2005) 0.78

Genetic contribution to C-reactive protein levels in severe obesity. Mol Genet Metab (2011) 0.78

Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients. Obesity (Silver Spring) (2012) 0.78

Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome. Diabetol Metab Syndr (2013) 0.78

The laval questionnaire: a new instrument to measure quality of life in morbid obesity. Health Qual Life Outcomes (2011) 0.78